Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption.

5-alpha-reductase inhibitor D. magna Endocrine distrusting chemical Finasteride Lipid metabolism Reproductive toxicity

Journal

Ecotoxicology and environmental safety
ISSN: 1090-2414
Titre abrégé: Ecotoxicol Environ Saf
Pays: Netherlands
ID NLM: 7805381

Informations de publication

Date de publication:
18 Jun 2024
Historique:
received: 22 02 2024
revised: 05 06 2024
accepted: 14 06 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 19 6 2024
Statut: aheadofprint

Résumé

Finasteride, a steroid 5-alpha reductase inhibitor, is commonly used for the treatment of benign prostatic hyperplasia and hair loss. However, despite continued use, its environmental implications have not been thoroughly investigated. Thus, we investigated the acute and chronic adverse impacts of finasteride on Daphnia magna, a crucial planktonic crustacean in freshwater ecosystems selected as bioindicator organism for understanding the ecotoxicological effects. Chronic exposure (for 23 days) to finasteride negatively affected development and reproduction, leading to reduced fecundity, delayed first brood, reduced growth, and reduced neonate size. Additionally, acute exposure (< 24 h) caused decreased expression levels of genes crucial for reproduction and development, especially EcR-A/B (ecdysone receptors), Jhe (juvenile hormone esterase), and Vtg2 (vitellogenin), with oxidative stress-related genes. Untargeted lipidomics/metabolomic analyses revealed lipidomic alteration, including 19 upregulated and 4 downregulated enriched lipid ontology categories, and confirmed downregulation of metabolites. Pathway analysis implicated significant effects on metabolic pathways, including the pentose phosphate pathway, histidine metabolism, beta-alanine metabolism, as well as alanine, aspartate, and glutamate metabolism. This comprehensive study unravels the intricate molecular and metabolic responses of D. magna to finasteride exposure, underscoring the multifaceted impacts of this anti-androgenic compound on a keystone species of freshwater ecosystems. The findings emphasize the importance of understanding the environmental repercussions of widely used pharmaceuticals to protect biodiversity in aquatic ecosystems.

Identifiants

pubmed: 38896907
pii: S0147-6513(24)00682-1
doi: 10.1016/j.ecoenv.2024.116606
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116606

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hyunki Cho (H)

Environmental Safety Group, KIST Europe Forschungsgesellschaft mbH, Saarbrücken 66123, Germany; Department of Pharmacy, Saarland University, Saarbrücken, Germany.

Si-Eun Sung (SE)

Biologische Experimentalphysik, Saarland University, Saarbrücken, Germany.

Giup Jang (G)

MetaDx Laboratory, Seoul, South Korea.

Maranda Esterhuizen (M)

University of Helsinki, Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, Lahti, Finland.

Chang Seon Ryu (CS)

Environmental Safety Group, KIST Europe Forschungsgesellschaft mbH, Saarbrücken 66123, Germany. Electronic address: changryu@kist-europe.de.

Youngsam Kim (Y)

Environmental Safety Group, KIST Europe Forschungsgesellschaft mbH, Saarbrücken 66123, Germany; Division of Energy & Environment Technology, University of Science & Technology, Daejeon 34113, South Korea. Electronic address: youngsam.kim@kist-europe.de.

Young Jun Kim (YJ)

Environmental Safety Group, KIST Europe Forschungsgesellschaft mbH, Saarbrücken 66123, Germany; Division of Energy & Environment Technology, University of Science & Technology, Daejeon 34113, South Korea.

Classifications MeSH